Up next

Autoplay

Current and future treatment options for cholangiocarcinoma

3 Views • 11/24/23
Share
Embed
administrator
administrator
Subscribers
0

John Bridgewater, BA, MBBS, MRCP, PhD, University College London Hospitals NHS Foundation Trust, London, UK, gives his thoughts on the current treatment of advanced cholangiocarcinoma in the UK, and discusses a new treatment option - pemigatinib - which is now available in the UK. Patients with advanced cholangiocarcinoma have historically been able to only access limited treatment options including surgery and chemotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay